This Phase 3 company is seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, and shares are moving up.

Late-stage theranostic company Spectral...

To read the full story on AllPennyStocks.com, click here.

Spectral Medical (TSX:EDT)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Spectral Medical
Spectral Medical (TSX:EDT)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Spectral Medical